戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nd predispose individuals to infertility and germ cell cancer.
2  retinoic acid signals can be dissociated in germ cell cancer.
3 sease and early in the treatment of relapsed germ cell cancer.
4 lar cancer are seminoma and non-seminomatous germ-cell cancer.
5  cycles in patients with favorable-prognosis germ-cell cancer.
6 ell, lung, ovarian, prostate, and testicular germ cell cancers.
7 mutation were soft tissue tumors, testicular germ cell cancers and neuro-blastomas.
8 a, but is associated with a risk of late non-germ-cell cancer and cardiovascular events.
9 eat shock protein response of germ cells and germ cell cancer are providing increasing interest in th
10 d postpubertal factors in the development of germ cell cancer as well as increased insight into the m
11 IV- or chemically induced, increases risk of germ cell cancer by 20 to 50 times that in the general p
12                            The International Germ Cell Cancer Collaborative Group (IGCCCG) criteria p
13  as poor risk according to the International Germ Cell Cancer Collaborative Group (IGCCCG) model.
14      The classification of the International Germ Cell Cancer Collaborative Group (IGCCCG) plays a pi
15                                International Germ Cell Cancer Collaborative Group (IGCCCG) prognostic
16 alysis, residual mass size and International Germ Cell Cancer Collaborative Group (IGCCCG) risk class
17 is issue in the context of the International Germ Cell Cancer Collaborative Group (IGCCCG) risk class
18 gnostic group according to the International Germ Cell Cancer Collaborative Group classification.
19  routine follow-up, 98% in the International Germ Cell Cancer Collaborative Group good prognosis grou
20 ata of trials according to the International Germ Cell Cancer Collaborative Group model, which has ev
21 rse outcome independent of the International Germ Cell Cancer Collaborative Group risk classification
22      The classification of the International Germ-Cell Cancer Collaborative Group (IGCCCG) has been a
23 in concentrations that matched International Germ Cell Cancer Consensus Group poor prognosis criteria
24  and sixty-three patients with International Germ Cell Cancer Consensus Group poor prognosis received
25          After controlling for International Germ Cell Cancer Cooperative Group risk group and percen
26 ents given systemic treatment for testicular germ cell cancer (GCC) are at increased risk for a secon
27  confirming a higher incidence of testicular germ cell cancer (GCC) in offspring of dizygous than in
28              A small number of patients with germ cell cancer (GCC) receive more than one line of tre
29  factor in the exquisite chemosensitivity of germ cell cancer has been high-lighted by a report demon
30           Retroperitoneal pathology revealed germ cell cancer in 53.5% of patients, teratoma in 34.2%
31 ng betaHCG, serum AFP level, redo RPLND, and germ cell cancer in the resected specimen.
32 HCG status, serum AFP level, redo RPLND, and germ cell cancer in the resected specimen.
33 cancers, scientific and clinical interest in germ cell cancer is increasing.
34 ish observation that the rising incidence of germ cell cancer is linked to a birth cohort effect; evi
35 the basis of pathologic review (lung cancer, germ cell cancer, lymphoma).
36 n on the X chromosome with susceptibility to germ cell cancer of the testis by its association with d
37                             A subset of male germ cell cancers presenting with advanced stage abundan
38                                   Testicular germ cell cancers remain one of the few solid tumors rou
39        To explore these FGF4 signals in male germ cell cancers, the multipotent human EC NTERA-2 clon
40 a included relapsed gonadal and extragonadal germ cell cancer unlikely to be cured by standard salvag
41                            For patients with germ cell cancer, various pulmonary toxicity risk factor
42 ete remissions in patients with disseminated germ cell cancer who relapse after cisplatin-etoposide-b
43 ow-up, pulmonary impairment in patients with germ cell cancer who were treated with BEP was limited.
44 ne hundred fourteen patients with metastatic germ cell cancer with elevated serum tumor markers after